Prognostic factors and significance of the revised 6th edition of the AJCC classification in patients with locally advanced nasopharyngeal carcinoma

Strahlentherapie und Onkologie

Volumn 182, Issue 8, 2006, Pages 458-466

  Kalogera Fountzila, Anna ^a   Karanikolas, Dimitrios ^a   Katodritis, Nikos ^b   Samantas, Epaminodas ^c   Sarafopoulos, Apostolos ^a   Ikonomou, Ippoliti ^a   Zamboglou, Nikolaos ^d   Tselis, Nikolaos ^d   Dimitriadis, Athanassios Sokratis ^a   Fountzilas, George ^e,f  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Bank of Cyprus Group Oncology Centre   (Cyprus)

^c AGII ANARGIRI CANCER HOSPITAL   (Greece)

^d Klinikum Offenbach   (Germany)

^e PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^f Hellenic Cooperative Oncology Group   (Greece)

Author keywords

Head and neck tumors; Nasopharyngeal carcinoma; Prognostic factors

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ADVANCED CANCER; AGE; AGED; CANCER CLASSIFICATION; CANCER INFILTRATION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CAVERNOUS SINUS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NASOPHARYNX CARCINOMA; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SURVIVAL RATE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; DATA INTERPRETATION, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 33747052061     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-006-1538-4     Document Type: Review

References (45)

1. American Joint Committee on Cancer staging manual, 3rd edn. Philadelphia: Lippincott, 1988.
2. American Joint Committee on Cancer staging manual, 5th edn. Philadelphia: Lippincott Raven, 1998.
3. American Joint Committee on Cancer staging manual, 6th edn. New York-Berlin-Heidelberg: Springer, 2002.
4. Batsakis JH. Tumors of the head and neck: clinical and pathological considerations, 2nd edn. Baltimore: Williams & Wilkins, 1970:188-99.
5. Beckmann G, Flentje M. Present status of treatment in nasopharyngeal carcinoma? Strahlenther Onkol 2003;179:283-91.
6. Bedwinek JM, Perez CA, Keys DL. Analysis of failures after definitive irradiation of epidermoid carcinoma of the nasopharynx. Cancer 1980;45:2725-9.
7. Beer KT, Buhler SS, Mullis P, et al. A microcystic adnexal carcinoma in the auditory canal 15 years after radiotherapy of a 12-year-old boy with nasopharynx carcinoma. Strahlenther Onkol 2005;181:405-10.
8. Chan ATC, Leung SF, Ngan RKC, et al. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 2005;97:536-9.
9. Chien CR, Chen SW, Hsieh CY, et al. Retrospective comparison of the AJCC 5th edition classification for nasopharyngeal carcinoma with AJCC 4th edition: an experience in Taiwan. Jpn J Clin Oncol 2001;31:363-9.
10. Chong VF, Fan YF, Khoo JB. Retropharyngeal lymphadenopathy in nasopharyngeal carcinoma. Eur J Radiol 1995;21:100-5.
11. Chua DTT, Sham JST, Kwong DLW, et al. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. Cancer 1996;78:202-10.
12. Chua DTT, Sham JST, Kwong DLW, et al. Retrograde lymphadenopathy in patients with nasopharyngeal carcinoma. A computed tomography-based study. Cancer 1997;79:869-77.
13. Chua DTT, Sham JST, Kwong DLW, et al. Evaluation of cervical nodal necrosis in nasopharyngeal carcinoma by computed tomography: incidence and prognostic significance. Head Neck 1997;19:266-75.
14. Chua DTT, Sham JST, Wei WI, et al. The predictive value of 1997 American Joint Committee on Cancer stage classification in determining failure patterns in nasopharyngeal carcinoma. Cancer 2001;92:2845-55.
15. Cooper JS, Cohen R, Stevens RE. A comparison of staging systems for nasopharyngeal carcinoma. Cancer 1998;83:213-9.
16. Dickson RI, Flores AD. Nasopharyngeal carcinoma: an evaluation of 134 patients treated between 1971-1980. Laryngoscope 1985;95:276-83.
17. Fandi A, Altun M, Azli N, et al. Nasopharyngeal cancer: epidemiology, staging, and treatment. Semin Oncol 1994;21:382-97.
18. Fountzilas G, Daniilidis J, Kosmidis P, et al. Platinum-based chemotherapy followed by radiotherapy of locally advanced nasopharyngeal cancer. A retrospective analysis of 39 cases. Acta Oncol 1991;30:831-4.
19. Fountzilas G, Tolis C, Kalogera-Fountzila A, et al. Induction chemotherapy with cisplatin, epirubicin and paclitaxel (CEP) followed by concomitant radiotherapy and weekly paclitaxel for the management of locally advanced nasopharyngeal carcinoma. A Hellenic Cooperative Oncology Group phase II study. Strahlenther Onkol 2005;181:223-30.
20. Gasmi J, Bachouchi M, Cvitkovic E, et al. Nasopharyngeal carcinoma: a medical oncology view point. The Gustave Roussy experience. Ann Oncol 1990;1:225-53.
21. Gruner A, Grabenbauer GG, Rödel C, et al. Nasopharyngeal carcinoma: only irradiation or simultaneous radiochemotherapy? Strahlenther Onkol 1999;175:591-6.
22. Heng DMK, Wee J, Fong KW, et al. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer 1999;85:1912-20.
23. Ho JHC. Stage classification of nasopharyngeal carcinoma: A review. JARC Sci Publ 1978;20:99-113.
24. International Nasopharynx Cancer Study Group. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (≥ N2, MO) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. Int J Radiat Oncol Biol Phys 1996;35:463-9.
25. Itami J, Mikata A, Arimizu N, et al. Radiation therapy of the nasopharyngeal cancer and its prognostic factors. Strahlenther Onkol 1998;164:446-50.
26. Janot F, Cvitkovic E, Piekarski JD, et al. Correlation between nodal density in contrasted scans and response to cisplatin-based chemotherapy in head and neck squamous cell carcinoma: a prospective validation. Head Neck 1993;15:222-9.
27. Jereczek-Fossa BA, Morra A, DeBraud F, et al. Hyperfractionated radiotherapy in locally advanced nasopharyngeal cancer. Strahlenther Onkol 2004;180:425-33.
28. King AD, Teo P, Lam WWM, et al. Paranasopharyngeal space involvement in nasopharyngeal cancer: detection by CT and MRI. Clin Oncol 2000;12:397-402.
29. Kuhnt T, Becker A, Pigorsch S, et al. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial. Strahlenther Onkol 2003;179:673-81.
30. Kurek R, Kalogera Fountzila A, Muskalla K, et al. Usefulness of tumor volumetry as a prognostic factor of survival in head and neck cancer. Strahlenther Onkol 2003;179:292-7.
31. Mancuso AA, Harnsberger HR, Muraki AS, et al. Computed tomography of cervical and retropharyngeal lymph nodes: normal anatomy, variants of normal, and application in staging head and neck cancer. Part II: Pathology. Radiology 1983;148:715-23.
32. McLauphlin MP, Mendenhall WM, Mancuso AA, et al. Retropharyngeal lymphadenopathy as a predictor outcome in sguamous cell carcinoma of the head and neck. Head Neck 1995;17:190-8.
33. Neel HB, Taylor WF, Pearson GR. Prognostic determinants and a new view of staging for patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 1985;944:529-37.
34. Olmi P, Fallai C, Colagrante S, et al. Staging and follow-up of nasopharyngeal carcinoma: magnetic resonance imaging versus computerized tomography. Int J. Radiat Oncol Biol Phys 1995;32:795-800.
35. Ozyar E, Yildiz F, Akyol FH, et al. Comparison of AJCC 1988 and 1997 classification for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1999;44:1079-85.
36. Proctor B. Anatomy of the Eustachian tube. Arch Otolaryngol Head Neck Surg 1973;97:2-8.
37. Sakata KI, Hareyama M, Tamakawa M, et al. Prognostic factors of nasopharynx tumors investigated by MRI imaging in the newly published TNM staging. Int J Radiat Oncol Biol Phys 1999;43:273-9.
38. Schäfer M, Munter M, Sterzing F, et al. Measurements of characteristics of time pattern in dose delivery in step-and-shoot IMRT. Strahlenther Onkol 2005;181:587-94.
39. Sham JST, Cheung YK, Choy D, et al. Nasopharyngeal carcinoma: CT evaluation of patterns of tumor spread. AJNR Am J Neuroradiol 1991;12:265-70.
40. Sham JST, Choy D. Prognostic value of paranasopharyngeal extention of nasopharyngeal carcinoma on local control and short-term survival. Head Neck 1991;13:298-310.
41. Silver AJ, Mawad ME, Sane P, et al. Computed tomography of the nasopharynx and related spaces. Part II: Pathology. Radiology 1983;147:733-8.
42. Spano J P, Basson P, Atlan D, et al. Nasopharyngeal carcinomas: an update. Eur J Cancer 2003;39:2121-35.
43. Teo P, Shiu W, Leung SF, et al. Prognostic factors in nasopharyngeal carcinoma investigated by computed tomography - an analysis of 659 patients. Radiother Oncol 1992;23:79-93.
44. Teo P, Yu P, Leung SF, et al. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinomas evaluated by computer tomography. Int J Radiat Oncol Biol Phys 1996;36:291-304.
45. Yousem DM, Som PM, Hackney DB, et al. Central necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT. Radiology 1992;182:753-75.